Human Cell Atlas Consortium Meets in Boston to Advance First Draft
The International Human Cell Atlas Consortium convenes in Boston this week as it prepares to release single-cell maps of major organs later in 2026.
The International Human Cell Atlas Consortium opened a meeting in Boston during the week of 16 June 2026, bringing together hundreds of scientists to review progress on a reference map of every cell type in the human body. Panels at the meeting include more than two dozen academics and industry leaders.
Genentech’s Aviv Regev, David Altshuler of Vertex Pharmaceuticals, and Eric Lander from the Broad Institute are among the scheduled participants.
The consortium was founded ten years before June 2026. Its first phase produced single-cell atlases of healthy tissues using 10x Genomics single-cell RNA sequencing technology. Later in 2026 the HCA plans to release a first draft covering all major organs and tissues.
The draft is intended to give researchers a baseline for studying how cells function in health. The next phase will shift focus to disease. Researchers intend to collect data on cell location, neighboring cells, and cell-to-cell communication, an approach known as spatial biology.
Several companies already sell tools for this work. Vizgen, Bruker, Illumina, Takara Bio, Bio-Techne, and 10x Genomics, a Bay Area firm, offer commercial spatial-biology or single-cell solutions. Scientists attending the Boston meeting will evaluate which of these platforms to adopt as the consortium expands its data collection into disease contexts.
